(Q39433032)

11 September 2017

title

A randomized study of the effects of tibolone and transdermal estrogen replacement therapy in postmenopausal women with uterine myomas (English)

1 reference

11 September 2017

1 reference

2

Bianchi S

1 reference

11 September 2017

Fedele L

1

1 reference

11 September 2017

Raffaelli R

series ordinal

3

1 reference

11 September 2017

Zanconato G

series ordinal

4

1 reference

11 September 2017

publication date

1 January 2000

1 reference

European Journal of Obstetrics Gynecology and Reproductive Biology

11 September 2017

published in

1 reference

11 September 2017

volume

88

1 reference

11 September 2017

issue

1

1 reference

11 September 2017

page(s)

91-94

1 reference

Progesterone: a critical role in the pathogenesis of uterine myomas

11 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2899%2900115-3

7 January 2021

Estrogen stimulation and tamoxifen inhibition of leiomyoma cell growth in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2899%2900115-3

7 January 2021

Regression of endometrial thickness in combination with reduced withdrawal bleeding as a progestational effect of tibolone in postmenopausal women on oestrogen replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2899%2900115-3

7 January 2021

The effects of hormone substitution in depot form on the uterus in a group of 50 perimenopausal women--a vaginosonographic study

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2899%2900115-3

7 January 2021

Effect of tibolone on postmenopausal women with myomas

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2899%2900115-3

7 January 2021

Endometrial and myometrial thickness and uterine blood flow in postmenopausal women: the influence of hormonal replacement therapy and age.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2899%2900115-3

7 January 2021

Does low-dose combination oral contraceptive use affect uterine size or menstrual flow in premenopausal women with leiomyomas?

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2899%2900115-3

7 January 2021

Effects of tibolone on serum concentrations of lipoprotein(a) in postmenopausal women.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2899%2900115-3

7 January 2021

Clinical experience with tibolone (Livial) over 8 years

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2899%2900115-3

7 January 2021

A 2-year study of lipid and lipoprotein changes in postmenopausal women with tibolone and estrogen-progestin.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2899%2900115-3

7 January 2021

Tibolone: influence on markers of cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2899%2900115-3

7 January 2021

10.1016/S0301-2115(99)00115-3

Identifiers

DOI

1 reference

11 September 2017

1 reference